<p>Adage Capital Partners GP L.L.C. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，其在直觉外科公司（NASDAQ:ISRG - 免费报告）的股份在第二季度减少了 4.4%。该基金在季度内出售了 16,903 股后，持有 369,584 股该医疗设备提供商的股票。根据其最近向证券交易委员会（SEC）提交的文件，Adage Capital Partners GP L.L.C. 持有的直觉外科公司股份约占 0.10%，价值为 200,836,000 美元。</p>
<p>获取 <strong>Intuitive Surgical</strong> 警报：</p>
<ul>
<li>1.34 亿美元的内部交易：这对 KMI、ISRG 和 QS 可能意味着什么</li>
</ul>
<p>其他机构投资者也对该公司的股份进行了增减。先锋集团（Vanguard Group Inc.）在第二季度将其在直觉外科公司的股份提高了 2.1%。先锋集团目前持有 33,335,833 股该医疗设备提供商的股票，价值为 18,115,025,000 美元，此前在该期间内又购买了 670,302 股。道富银行（State Street Corp）在第二季度将其在直觉外科公司的股份提高了 1.2%。道富银行目前持有 15,552,203 股该医疗设备提供商的股票，价值为 8,451,223,000 美元，此前在上个季度又购买了 182,871 股。Geode Capital Management LLC 在第二季度将其在直觉外科公司的持股提高了 1.4%。Geode Capital Management LLC 目前持有 8,188,685 股该医疗设备提供商的股票，价值为 4,429,590,000 美元，此前又购买了 109,904 股。挪威银行（Norges Bank）在第二季度获得了直觉外科公司的新头寸，价值为 2,569,260,000 美元。最后，景顺（Invesco Ltd.）在第二季度将其在直觉外科公司的股份提高了 4.8%。景顺目前持有 4,421,133 股该医疗设备提供商的股票，价值为 2,402,488,000 美元，此前又收购了 201,159 股。目前 83.64% 的股票由机构投资者持有。</p>
<h2>直觉外科的内部买卖</h2>
<p>在其他直觉外科的新闻中，执行副总裁 Brian Edward Miller 于 11 月 10 日星期一出售了 3,500 股直觉外科的股票。该股票以平均价格 575.00 美元出售，总交易额为 2,012,500.00 美元。交易完成后，该执行副总裁直接持有 5,758 股公司的股票，价值为 3,310,850 美元。此次交易使其持股减少了 37.81%。该交易已在证券交易委员会的法律文件中披露，可通过 SEC 网站获取。此外，首席执行官 David J. Rosa 于 10 月 24 日星期五出售了 24,500 股该股票。该股票以平均价格 547.55 美元出售，总交易额为 13,414,975.00 美元。交易完成后，首席执行官持有 234,256 股公司的股票，价值约为 128,266,872.80 美元。这代表其持股减少了 9.47%。有关此次出售的更多细节可在官方 SEC 披露中找到。在上个季度，内部人士出售了 109,043 股公司股票，价值为 60,816,225 美元。目前 0.70% 的股票由内部人士持有。</p>
<h2>直觉外科股票表现</h2>
<ul>
<li>在特朗普关税政策下表现突出的前三只股票</li>
</ul>
<p>NASDAQ ISRG 的股票在周五开盘价为 542.32 美元。该股票的市值为 1944.1 亿美元，市盈率为 71.74，PEG 比率为 5.03，贝塔值为 1.68。直觉外科公司在过去 52 周的最低价为 425.00 美元，最高价为 616.00 美元。该公司的 50 日简单移动平均线为 529.62 美元，200 日简单移动平均线为 506.00 美元。</p>
<p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近于 10 月 21 日星期二发布了季度财报。该医疗设备提供商报告本季度每股收益为 2.40 美元，超出市场共识预期的 1.99 美元，超出幅度为 0.41 美元。该公司在本季度的收入为 25.1 亿美元，而市场共识预期为 24.1 亿美元。直觉外科的股本回报率为 15.08%，净利润率为 28.58%。该公司的季度收入较去年同期增长了 22.9%。在去年同期，该公司每股收益为 1.84 美元。根据市场分析师的预测，直觉外科公司预计今年将发布 6.43 美元的每股收益。</p>
<h2>分析师评级上调和下调</h2>
<ul>
<li>为什么直觉外科对长期投资者来说是个明智的选择</li>
</ul>
<p>几家研究机构最近对 ISRG 进行了评估。加拿大皇家银行（Royal Bank Of Canada）在 10 月 22 日的研究报告中将直觉外科的目标价设定为 625.00 美元，并给予该股票 “跑赢大盘” 的评级。高盛集团（Goldman Sachs Group）在 10 月 22 日的报告中将直觉外科的目标价从 567.00 美元上调至 621.00 美元，并给予该股票 “买入” 评级。Zacks Research 在 10 月 24 日的研究报告中将直觉外科的评级从 “持有” 上调至 “强烈买入”。Truist Financial 在 10 月 22 日的研究报告中将直觉外科的目标价设定为 620.00 美元，并给予该股票 “买入” 评级。最后，Raymond James Financial 在 10 月 22 日的研究报告中将直觉外科的目标价设定为 603.00 美元，并给予该公司 “跑赢大盘” 的评级。两位投资分析师对该股票给予了 “强烈买入” 评级，十六位给予了 “买入” 评级，八位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 608.79 美元。</p>
<p><strong>查看我们对直觉外科的最新分析</strong></p>
<h2>关于直觉外科</h2>
<p>（免费报告）</p>
<p>直觉外科公司（Intuitive Surgical, Inc）开发、制造和销售产品，使医生和医疗服务提供者能够提高美国及国际上微创护理的质量和可及性。该公司提供达芬奇手术系统（da Vinci Surgical System），该系统采用微创方法进行复杂手术；以及 Ion 内腔系统（Ion endoluminal system），其商业产品扩展到诊断程序，使微创肺活检成为可能。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们认为比直觉外科更好的股票</li>
<li>现在可以购买的三只巨头成长股</li>
<li>Synopsys 因 Ansys 整合推动增长而出现看涨转变</li>
<li>投资者必须了解的场外交易（OTC）股票</li>
<li>你能给自己最好的节日礼物是什么？好市多股票</li>
<li>什么是标准普尔 500 指数，它与其他指数有何不同</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
<p>在你考虑直觉外科之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
<p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

直觉外科

<p>Adage Capital Partners GP L.L.C. 在第二季度减少了对直觉外科（Intuitive Surgical, Inc.）的持股比例，下降了 4.4%，目前持有 369,584 股，价值 2 亿零 840 万美元。其他机构投资者如先锋集团（Vanguard）、道富集团（State Street）和 Geode 也调整了他们的持仓。内部交易方面，执行副总裁 Brian Miller 和首席执行官 David Rosa 进行了大量出售。直觉外科报告了强劲的第三季度财报，收入增长了 22.9%。分析师们保持乐观，加拿大皇家银行（Royal Bank of Canada）设定了 625 美元的目标价</p>

<p>Adage Capital Partners GP L.L.C. trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 369,584 shares of the medical equipment provider's stock after selling 16,903 shares during the quarter. Adage Capital Partners GP L.L.C. owned approximately 0.10% of Intuitive Surgical worth $200,836,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p>
<div class="lb-trans"><p>Adage Capital Partners GP L.L.C. 在最近向证券交易委员会（SEC）提交的 13F 表格中披露，其在直觉外科公司（NASDAQ:ISRG - 免费报告）的股份在第二季度减少了 4.4%。该基金在季度内出售了 16,903 股后，持有 369,584 股该医疗设备提供商的股票。根据其最近向证券交易委员会（SEC）提交的文件，Adage Capital Partners GP L.L.C. 持有的直觉外科公司股份约占 0.10%，价值为 200,836,000 美元。</p>
</div><p>Get <strong>Intuitive Surgical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Intuitive Surgical</strong> 警报：</p>
</div><ul>
<li>$134M in Insider Moves: What It Might Mean for KMI, ISRG and QS</li>
</ul>
<div class="lb-trans"><ul>
<li>1.34 亿美元的内部交易：这对 KMI、ISRG 和 QS 可能意味着什么</li>
</ul>
</div><p>Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider's stock worth $18,115,025,000 after purchasing an additional 670,302 shares during the period. State Street Corp raised its stake in Intuitive Surgical by 1.2% during the second quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider's stock worth $8,451,223,000 after buying an additional 182,871 shares during the last quarter. Geode Capital Management LLC lifted its holdings in Intuitive Surgical by 1.4% in the second quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider's stock valued at $4,429,590,000 after buying an additional 109,904 shares during the period. Norges Bank acquired a new position in Intuitive Surgical in the second quarter valued at $2,569,260,000. Finally, Invesco Ltd. boosted its position in Intuitive Surgical by 4.8% during the second quarter. Invesco Ltd. now owns 4,421,133 shares of the medical equipment provider's stock valued at $2,402,488,000 after acquiring an additional 201,159 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.</p>
<div class="lb-trans"><p>其他机构投资者也对该公司的股份进行了增减。先锋集团（Vanguard Group Inc.）在第二季度将其在直觉外科公司的股份提高了 2.1%。先锋集团目前持有 33,335,833 股该医疗设备提供商的股票，价值为 18,115,025,000 美元，此前在该期间内又购买了 670,302 股。道富银行（State Street Corp）在第二季度将其在直觉外科公司的股份提高了 1.2%。道富银行目前持有 15,552,203 股该医疗设备提供商的股票，价值为 8,451,223,000 美元，此前在上个季度又购买了 182,871 股。Geode Capital Management LLC 在第二季度将其在直觉外科公司的持股提高了 1.4%。Geode Capital Management LLC 目前持有 8,188,685 股该医疗设备提供商的股票，价值为 4,429,590,000 美元，此前又购买了 109,904 股。挪威银行（Norges Bank）在第二季度获得了直觉外科公司的新头寸，价值为 2,569,260,000 美元。最后，景顺（Invesco Ltd.）在第二季度将其在直觉外科公司的股份提高了 4.8%。景顺目前持有 4,421,133 股该医疗设备提供商的股票，价值为 2,402,488,000 美元，此前又收购了 201,159 股。目前 83.64% 的股票由机构投资者持有。</p>
</div><h2>Insider Buying and Selling at Intuitive Surgical</h2>
<div class="lb-trans"><h2>直觉外科的内部买卖</h2>
</div><p>In other Intuitive Surgical news, EVP Brian Edward Miller sold 3,500 shares of Intuitive Surgical stock in a transaction on Monday, November 10th. The shares were sold at an average price of $575.00, for a total transaction of $2,012,500.00. Following the transaction, the executive vice president directly owned 5,758 shares of the company's stock, valued at $3,310,850. The trade was a 37.81% decrease in their position. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available through the SEC website. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction dated Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer owned 234,256 shares of the company's stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 109,043 shares of company stock worth $60,816,225. 0.70% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在其他直觉外科的新闻中，执行副总裁 Brian Edward Miller 于 11 月 10 日星期一出售了 3,500 股直觉外科的股票。该股票以平均价格 575.00 美元出售，总交易额为 2,012,500.00 美元。交易完成后，该执行副总裁直接持有 5,758 股公司的股票，价值为 3,310,850 美元。此次交易使其持股减少了 37.81%。该交易已在证券交易委员会的法律文件中披露，可通过 SEC 网站获取。此外，首席执行官 David J. Rosa 于 10 月 24 日星期五出售了 24,500 股该股票。该股票以平均价格 547.55 美元出售，总交易额为 13,414,975.00 美元。交易完成后，首席执行官持有 234,256 股公司的股票，价值约为 128,266,872.80 美元。这代表其持股减少了 9.47%。有关此次出售的更多细节可在官方 SEC 披露中找到。在上个季度，内部人士出售了 109,043 股公司股票，价值为 60,816,225 美元。目前 0.70% 的股票由内部人士持有。</p>
</div><h2>Intuitive Surgical Stock Performance</h2>
<div class="lb-trans"><h2>直觉外科股票表现</h2>
</div><ul>
<li>Top 3 Stocks Powering Through Trump’s Tariff Policies</li>
</ul>
<div class="lb-trans"><ul>
<li>在特朗普关税政策下表现突出的前三只股票</li>
</ul>
</div><p>Shares of NASDAQ ISRG opened at $542.32 on Friday. The stock has a market cap of $194.41 billion, a price-to-earnings ratio of 71.74, a PEG ratio of 5.03 and a beta of 1.68. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The firm's 50-day simple moving average is $529.62 and its 200 day simple moving average is $506.00.</p>
<div class="lb-trans"><p>NASDAQ ISRG 的股票在周五开盘价为 542.32 美元。该股票的市值为 1944.1 亿美元，市盈率为 71.74，PEG 比率为 5.03，贝塔值为 1.68。直觉外科公司在过去 52 周的最低价为 425.00 美元，最高价为 616.00 美元。该公司的 50 日简单移动平均线为 529.62 美元，200 日简单移动平均线为 506.00 美元。</p>
</div><p>Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company's quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the business posted $1.84 earnings per share. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.</p>
<div class="lb-trans"><p>直觉外科（NASDAQ:ISRG - 获取免费报告）最近于 10 月 21 日星期二发布了季度财报。该医疗设备提供商报告本季度每股收益为 2.40 美元，超出市场共识预期的 1.99 美元，超出幅度为 0.41 美元。该公司在本季度的收入为 25.1 亿美元，而市场共识预期为 24.1 亿美元。直觉外科的股本回报率为 15.08%，净利润率为 28.58%。该公司的季度收入较去年同期增长了 22.9%。在去年同期，该公司每股收益为 1.84 美元。根据市场分析师的预测，直觉外科公司预计今年将发布 6.43 美元的每股收益。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调和下调</h2>
</div><ul>
<li>Why Intuitive Surgical Is a No-Brainer for Long-Term Investors</li>
</ul>
<div class="lb-trans"><ul>
<li>为什么直觉外科对长期投资者来说是个明智的选择</li>
</ul>
</div><p>Several research firms have recently weighed in on ISRG. Royal Bank Of Canada set a $625.00 price objective on Intuitive Surgical and gave the stock an &#34;outperform&#34; rating in a research report on Wednesday, October 22nd. The Goldman Sachs Group lifted their target price on Intuitive Surgical from $567.00 to $621.00 and gave the stock a &#34;buy&#34; rating in a report on Wednesday, October 22nd. Zacks Research raised Intuitive Surgical from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research note on Friday, October 24th. Truist Financial set a $620.00 price objective on shares of Intuitive Surgical and gave the stock a &#34;buy&#34; rating in a research report on Wednesday, October 22nd. Finally, Raymond James Financial set a $603.00 price objective on shares of Intuitive Surgical and gave the company an &#34;outperform&#34; rating in a research note on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $608.79.</p>
<div class="lb-trans"><p>几家研究机构最近对 ISRG 进行了评估。加拿大皇家银行（Royal Bank Of Canada）在 10 月 22 日的研究报告中将直觉外科的目标价设定为 625.00 美元，并给予该股票 “跑赢大盘” 的评级。高盛集团（Goldman Sachs Group）在 10 月 22 日的报告中将直觉外科的目标价从 567.00 美元上调至 621.00 美元，并给予该股票 “买入” 评级。Zacks Research 在 10 月 24 日的研究报告中将直觉外科的评级从 “持有” 上调至 “强烈买入”。Truist Financial 在 10 月 22 日的研究报告中将直觉外科的目标价设定为 620.00 美元，并给予该股票 “买入” 评级。最后，Raymond James Financial 在 10 月 22 日的研究报告中将直觉外科的目标价设定为 603.00 美元，并给予该公司 “跑赢大盘” 的评级。两位投资分析师对该股票给予了 “强烈买入” 评级，十六位给予了 “买入” 评级，八位给予了 “持有” 评级，一位给予了 “卖出” 评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “适度买入”，共识目标价为 608.79 美元。</p>
</div><p><strong>Check Out Our Latest Analysis on Intuitive Surgical</strong></p>
<div class="lb-trans"><p><strong>查看我们对直觉外科的最新分析</strong></p>
</div><h2>About Intuitive Surgical</h2>
<div class="lb-trans"><h2>关于直觉外科</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.</p>
<div class="lb-trans"><p>直觉外科公司（Intuitive Surgical, Inc）开发、制造和销售产品，使医生和医疗服务提供者能够提高美国及国际上微创护理的质量和可及性。该公司提供达芬奇手术系统（da Vinci Surgical System），该系统采用微创方法进行复杂手术；以及 Ion 内腔系统（Ion endoluminal system），其商业产品扩展到诊断程序，使微创肺活检成为可能。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Intuitive Surgical</li>
<li>3 Monster Growth Stocks to Buy Now</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>What Investors Must Know About Over-the-Counter (OTC) Stocks</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>What is the S&amp;P 500 and How It is Distinct from Other Indexes</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比直觉外科更好的股票</li>
<li>现在可以购买的三只巨头成长股</li>
<li>Synopsys 因 Ansys 整合推动增长而出现看涨转变</li>
<li>投资者必须了解的场外交易（OTC）股票</li>
<li>你能给自己最好的节日礼物是什么？好市多股票</li>
<li>什么是标准普尔 500 指数，它与其他指数有何不同</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SVNSRw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ISRG"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Intuitive Surgical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在直觉外科吗？</h2>
</div><p>Before you consider Intuitive Surgical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑直觉外科之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而直觉外科并不在名单上。</p>
</div><p>While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然直觉外科目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Adage Capital Partners GP L.L.C. 在 Intuitive Surgical, Inc.持有价值 2.0084 亿美元的股票